Pancreatic Cancer Research

ResearcherVita-Salute San Raffaele UniversityActive in the last 2 years

Lucia B. De Monte

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9406-7809; OpenAlex author ID A5060488643. Sources: OpenAlex.

Their work

Papers
9 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 9

  1. Anakinra-Loaded Sphingomyelin Nanosystems Modulate In Vitro IL-1-Dependent Pro-Tumor Inflammation in Pancreatic Cancer. Co-author DOI 10.3390/ijms25158085↗
  2. Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer. Co-author DOI 10.1016/j.ebiom.2023.104819↗
  3. Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers15143704↗
  4. B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/2162402x.2020.1794359↗
  5. The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreati… First author DOI 10.1186/s40425-019-0521-4↗
  6. Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients. Co-author DOI 10.1158/0008-5472.can-15-1801-t↗
  7. Immune infiltrates as predictive markers of survival in pancreatic cancer patients. First author DOI 10.3389/fphys.2013.00210↗
  8. Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer. First author DOI 10.4161/onci.1.1.17939↗
  9. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancrea… Co-author DOI 10.1084/jem.20101876↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maria Pia Protti · 9 shared papers, 2011–2024 · strength 0.92
  2. Massimo Falconi · 5 shared papers, 2016–2023 · strength 0.52
  3. Michele Reni · 4 shared papers, 2011–2023 · strength 0.37
  4. Claudio Doglioni · 4 shared papers, 2011–2023 · strength 0.31
  5. Gianpaolo Balzano · 3 shared papers, 2016–2023 · strength 0.28
  6. Marcelina Abal-Sanisidro · 1 shared paper, 2024 · strength 0.24
  7. María de la Fuente · 1 shared paper, 2024 · strength 0.24
  8. Stefano Crippa · 2 shared papers, 2020–2023 · strength 0.24
  9. Claudia Minici · 2 shared papers, 2020–2023 · strength 0.23
  10. Emanuel Della‐Torre · 2 shared papers, 2020–2023 · strength 0.23
  11. Paolo Giorgio Arcidiacono · 2 shared papers, 2020–2023 · strength 0.23
  12. Giulio Belfiori · 1 shared paper, 2023 · strength 0.15
  13. Marco Schiavo Lena · 1 shared paper, 2023 · strength 0.15
  14. Sabrina Gloria Giulia Testoni · 1 shared paper, 2023 · strength 0.14
  15. Maria Chiara Petrone · 1 shared paper, 2023 · strength 0.14
  16. Francesco DE COBELLI · 1 shared paper, 2023 · strength 0.14
  17. Gabriele Capurso · 1 shared paper, 2023 · strength 0.14
  18. Emanuela Brunetto · 2 shared papers, 2016–2019 · strength 0.13
  19. Erica Dugnani · 1 shared paper, 2020 · strength 0.09
  20. Vikram Deshpande · 1 shared paper, 2020 · strength 0.09
  21. Lorenzo Piemonti · 1 shared paper, 2020 · strength 0.09
  22. Sonja M. Wörmann · 1 shared paper, 2016 · strength 0.05
  23. Hana Algül · 1 shared paper, 2016 · strength 0.05
  24. Marco Braga · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.